Slide Presentations: Monday, October 24, 2011 |

Resolution of Thromboemboli in Patients With Submassive Acute Pulmonary Embolism and Related Prognostic Factors FREE TO VIEW

Marc Meysman, MD; Hendrik Everaert, PhD; Shane Hanon, MD; Eef Vanderhelst, MD; Walter Vincken, PhD
Chest. 2011;140(4_MeetingAbstracts):963A. doi:10.1378/chest.1114969
Text Size: A A A
Published online


PURPOSE: The proportion of resolution of acute pulmonary thrombi varies from 35 to 43 % in studies that used perfusion scintigraphy performed at variable time points. We examined factors which could predict clot resolution.

METHODS: A single-center prospective observational cohort study in patients with acute sub-massive PE Data collected at baseline were: age, BMI, history of previous venous thromboembolism (HVTE), Charlson's comorbidity score (CcS), plasma troponin-t and D-dimer levels, Pulmonary Embolism Severity Score (PESS) and tricuspid regurgitation jet velocity (TRJ). Ventilation/perfusion scintigraphy (V/Q scan) was done at baseline, after one week and after six months (m) of anticoagulant treatment. If V/Q scan was abnormal at 6 m, prolongation of treatment with 3 m was proposed. Patients with persistent abnormal V/Q scan received an angio-CT if no other reasons for anticoagulation were present.

RESULTS: During the study period 83 patients were admitted for PE. 31 patients were excluded, 5 lost to follow-up. 47 patients, 22 men and 25 women completed the study. Mean age was 61 year (range 22-83), mean BMI 27,1 (range 16,4-38,4). At 1 week 5/47 (10.6%) and at 6m 20/47 (42.5%) had normalized V/Q scan. Five other patients (3 with matched V/Q defects, 1 with a new defect and 1 with no V/Q scan) had normal angio-CT at 6 m. The remaining 22 patients had persistent V/Q mismatch at 6 m. 10/22 agreed for anticoagulation to be prolonged by 3m. V/Q normalised in one. In the remaining 9, V/Q defects persisted. 5/9 had an abnormal angio-CT. 6/22 had a normal angio-CT at 6 m. In 4/22 anticoagulation was continued for other reasons. Two had no reassessment. We found no correlation between the persistence of perfusion defects on V/Q scan and HVTE, BMI, CcS, troponin-t , D-dimer level, PESS, nor TRJ.

CONCLUSIONS: 42.5 % of patients with PE have still mismatched perfusion defects at V/Q after 6 m of treatment. Baseline characteristics do not predict normalisation of perfusion defects. The agreement between pulmonary scintigraphy and angio-CT in detecting residual thrombi seems poor.

CLINICAL IMPLICATIONS: The duration of anticoagulation treatment after acute PE can not be based on normalisation of V/Q images alone. Further study of the clinical significance and cause of persistent scintigraphic perfusion abnormalities should be performed.

DISCLOSURE: The following authors have nothing to disclose: Marc Meysman, Hendrik Everaert, Shane Hanon, Eef Vanderhelst, Walter Vincken

No Product/Research Disclosure Information

01:30 PM - 02:45 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543